Labeler · US market

ScieGen Pharmaceuticals, Inc.

ScieGen Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 60 drug concepts (60 currently active) across 523 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes50228

Active drugs60

Registrations187 active / 187

Packages523

Sole supplier of0 drugs

Portfolio60 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Pregabalin capsule	rx	16	40	SUPPLYING
Aripiprazole tablet	rx	12	24	SUPPLYING
Bupropion Hydrochloride tablet, film coated, extended release	rx	6	23	SUPPLYING
Metformin Hydrochloride tablet	rx	3	16	SUPPLYING
Rosuvastatin tablet, film coated	rx	4	16	SUPPLYING
Quetiapine tablet, film coated, extended release	rx	5	15	SUPPLYING
Diltiazem Hydrochloride tablet	rx	4	15	SUPPLYING
Levetiracetam tablet, film coated	rx	4	14	SUPPLYING
Celecoxib capsule	rx	4	14	SUPPLYING
Carbidopa And Levodopa tablet	rx	3	12	SUPPLYING
Naproxen tablet	rx	3	12	SUPPLYING
Gabapentin tablet	rx	4	12	SUPPLYING
Diltiazem Hydrochloride tablet, extended release	rx	6	12	SUPPLYING
Amlodipine And Olmesartan Medoxomil tablet, film coated	rx	4	12	SUPPLYING
Metformin Hydrochloride Extended-Release Tablets tablet, film coated, extended release	rx	4	12	SUPPLYING
Lacosamide tablet, film coated	rx	4	12	SUPPLYING
Pramipexole Dihydrochloride tablet	rx	6	12	SUPPLYING
Gabapentin capsule	rx	3	11	SUPPLYING
Fluoxetine Hydrochloride capsule	rx	3	11	SUPPLYING
Sertraline Hydrochloride tablet, film coated	rx	3	9	SUPPLYING
Olmesartan Medoxomil tablet, film coated	rx	3	9	SUPPLYING
Olmesartan Medoxomil And Hydrochlorothiazide tablet, film coated	rx	3	9	SUPPLYING
Droxidopa capsule	rx	3	9	SUPPLYING
Valsartan tablet	rx	4	8	SUPPLYING
Hydralazine Hydrochloride tablet	rx	4	8	SUPPLYING
Atorvastatin Calcium tablet, film coated	rx	4	8	SUPPLYING
Lamotrigine tablet, orally disintegrating	rx	4	8	SUPPLYING
Naproxen Sodium tablet	rx	2	8	SUPPLYING
Enalapril Maleate tablet	rx	4	8	SUPPLYING
Fexofenadine Hcl tablet, film coated	otc	2	8	SUPPLYING
Clopidogrel Bisulfate tablet, film coated	rx	2	7	SUPPLYING
Carbidopa And Levodopa tablet, extended release	rx	2	6	SUPPLYING
Benztropine Mesylate tablet	rx	3	6	SUPPLYING
Naproxen And Esomeprazole Magnesium tablet, delayed release	rx	2	6	SUPPLYING
Ranolazine tablet, film coated, extended release	rx	2	6	SUPPLYING
Ticagrelor tablet	rx	2	6	SUPPLYING
Solifenacin Succinate tablet, film coated	rx	2	6	SUPPLYING
Irbesartan tablet	rx	3	6	SUPPLYING
Fluoxetine tablet, film coated	rx	2	6	SUPPLYING
Nabumetone tablet	rx	2	6	SUPPLYING

Showing 40 of 60 drugs by package count.

At a glance

TypeLabeler
Labeler codes50228
Filing names1
Drugs (active)60
Drugs (all time)60
US registrations187
Packages523

Recent events

Shortages, recalls, and registration changes across all filing names.

Feb 17, 2023
RECALLRecall (Class III): Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppaug…
Oct 29, 2018
RECALLRecall (Class II): Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69…
Oct 29, 2018
RECALLRecall (Class II): GSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90), Rx…
Oct 29, 2018
RECALLRecall (Class II): GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge,…
Oct 29, 2018
RECALLRecall (Class II): Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count bottle (NDC 69367-119-…
Oct 29, 2018
RECALLRecall (Class II): Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) 90-count bottle (NDC 69367-12…
Oct 29, 2018
RECALLRecall (Class II): GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), R…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.